388 related articles for article (PubMed ID: 26061384)
1. The application of nanomaterials in controlled drug delivery for bone regeneration.
Shi S; Jiang W; Zhao T; Aifantis KE; Wang H; Lin L; Fan Y; Feng Q; Cui FZ; Li X
J Biomed Mater Res A; 2015 Dec; 103(12):3978-92. PubMed ID: 26061384
[TBL] [Abstract][Full Text] [Related]
2. Nanomaterials for bone tissue regeneration: updates and future perspectives.
J Hill M; Qi B; Bayaniahangar R; Araban V; Bakhtiary Z; Doschak MR; Goh BC; Shokouhimehr M; Vali H; Presley JF; Zadpoor AA; Harris MB; Abadi PP; Mahmoudi M
Nanomedicine (Lond); 2019 Nov; 14(22):2987-3006. PubMed ID: 31779522
[TBL] [Abstract][Full Text] [Related]
3. Nanobiotechnology: protein-nanomaterial interactions.
Kane RS; Stroock AD
Biotechnol Prog; 2007; 23(2):316-9. PubMed ID: 17335286
[TBL] [Abstract][Full Text] [Related]
4. Controlled release of drugs in electrosprayed nanoparticles for bone tissue engineering.
Jayaraman P; Gandhimathi C; Venugopal JR; Becker DL; Ramakrishna S; Srinivasan DK
Adv Drug Deliv Rev; 2015 Nov; 94():77-95. PubMed ID: 26415888
[TBL] [Abstract][Full Text] [Related]
5. Advanced drug delivery nanosystems: perspectives and regulatory issues.
Demetzos C
Adv Exp Med Biol; 2015; 822():195-8. PubMed ID: 25416990
[TBL] [Abstract][Full Text] [Related]
6. Dual-controlled release system of drugs for bone regeneration.
Kim YH; Tabata Y
Adv Drug Deliv Rev; 2015 Nov; 94():28-40. PubMed ID: 26079284
[TBL] [Abstract][Full Text] [Related]
7. Use of degradable and nondegradable nanomaterials for controlled release.
Wan WK; Yang L; Padavan DT
Nanomedicine (Lond); 2007 Aug; 2(4):483-509. PubMed ID: 17716133
[TBL] [Abstract][Full Text] [Related]
8. From nano- to macro-scale: nanotechnology approaches for spatially controlled delivery of bioactive factors for bone and cartilage engineering.
Santo VE; Gomes ME; Mano JF; Reis RL
Nanomedicine (Lond); 2012 Jul; 7(7):1045-66. PubMed ID: 22846091
[TBL] [Abstract][Full Text] [Related]
9. Silica-based mesoporous nanobiomaterials as promoter of bone regeneration process.
Shadjou N; Hasanzadeh M
J Biomed Mater Res A; 2015 Nov; 103(11):3703-16. PubMed ID: 26011776
[TBL] [Abstract][Full Text] [Related]
10. Nanotechnology controlled drug delivery for treating bone diseases.
Yang L; Webster TJ
Expert Opin Drug Deliv; 2009 Aug; 6(8):851-64. PubMed ID: 19637973
[TBL] [Abstract][Full Text] [Related]
11. Micro and nanotechnologies for bone regeneration: Recent advances and emerging designs.
Mohammadi M; Mousavi Shaegh SA; Alibolandi M; Ebrahimzadeh MH; Tamayol A; Jaafari MR; Ramezani M
J Control Release; 2018 Mar; 274():35-55. PubMed ID: 29410062
[TBL] [Abstract][Full Text] [Related]
12. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
[TBL] [Abstract][Full Text] [Related]
13. Advanced Black Phosphorus Nanomaterials for Bone Regeneration.
Qing Y; Li R; Li S; Li Y; Wang X; Qin Y
Int J Nanomedicine; 2020; 15():2045-2058. PubMed ID: 32273701
[TBL] [Abstract][Full Text] [Related]
14. The concept of bio-corona in modulating the toxicity of engineered nanomaterials (ENM).
Westmeier D; Stauber RH; Docter D
Toxicol Appl Pharmacol; 2016 May; 299():53-7. PubMed ID: 26592323
[TBL] [Abstract][Full Text] [Related]
15. Advances in Nanotechnology for the Treatment of Osteoporosis.
Barry M; Pearce H; Cross L; Tatullo M; Gaharwar AK
Curr Osteoporos Rep; 2016 Jun; 14(3):87-94. PubMed ID: 27048473
[TBL] [Abstract][Full Text] [Related]
16. Bone regeneration with biomaterials and active molecules delivery.
D' Este M; Eglin D; Alini M; Kyllonen L
Curr Pharm Biotechnol; 2015; 16(7):582-605. PubMed ID: 25658379
[TBL] [Abstract][Full Text] [Related]
17. Smart chemistry-based nanosized drug delivery systems for systemic applications: A comprehensive review.
Ramasamy T; Ruttala HB; Gupta B; Poudel BK; Choi HG; Yong CS; Kim JO
J Control Release; 2017 Jul; 258():226-253. PubMed ID: 28472638
[TBL] [Abstract][Full Text] [Related]
18. The potential roles of nanobiomaterials in distraction osteogenesis.
Makhdom AM; Nayef L; Tabrizian M; Hamdy RC
Nanomedicine; 2015 Jan; 11(1):1-18. PubMed ID: 24965757
[TBL] [Abstract][Full Text] [Related]
19. Review of emerging nanotechnology in bone regeneration: progress, challenges, and perspectives.
Hajiali H; Ouyang L; Llopis-Hernandez V; Dobre O; Rose FRAJ
Nanoscale; 2021 Jun; 13(23):10266-10280. PubMed ID: 34085085
[TBL] [Abstract][Full Text] [Related]
20. Sustained release carriers used to delivery bone morphogenetic proteins in the bone healing process.
Issa JP; Bentley MV; Iyomasa MM; Sebald W; De Albuquerque RF
Anat Histol Embryol; 2008 Jun; 37(3):181-7. PubMed ID: 18070240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
